Literature DB >> 25379377

Establishment of c-myc-immortalized Kupffer cell line from a C57BL/6 mouse strain.

Hiroshi Kitani1, Chisato Sakuma1, Takato Takenouchi1, Mitsuru Sato1, Miyako Yoshioka2, Noriko Yamanaka2.   

Abstract

We recently demonstrated in several mammalian species, a novel procedure to obtain liver-macrophages (Kupffer cells) in sufficient numbers and purity using a mixed primary culture of hepatocytes. In this study, we applied this method to the C57BL/6 mouse liver and established an immortalized Kupffer cell line from this mouse strain. The hepatocytes from the C57BL/6 adult mouse liver were isolated by a two-step collagenase perfusion method and cultured in T25 culture flasks. Similar to our previous studies, the mouse hepatocytes progressively changed their morphology into a fibroblastic appearance after a few days of culture. After 7-10 days of culture, Kupffer-like cells, which were contaminants in the hepatocyte fraction at the start of the culture, actively proliferated on the mixed fibroblastic cell sheet. At this stage, a retroviral vector containing the human c-myc oncogene and neomycin resistance gene was introduced into the mixed culture. Gentle shaking of the culture flask, followed by the transfer and brief incubation of the culture supernatant, resulted in a quick and selective adhesion of Kupffer cells to a plastic dish surface. After selection with G418 and cloning by limiting dilutions, a clonal cell line (KUP5) was established. KUP5 cells displayed typical macrophage morphology and were stably passaged at 4-5 days intervals for more than 5 months, with a population doubling time of 19 h. KUP5 cells are immunocytochemically positive for mouse macrophage markers, such as Mac-1, F4/80. KUP5 cells exhibited substantial phagocytosis of polystyrene microbeads and the release of inflammatory cytokines upon lipopolysaccharide stimulation. Taken together, KUP5 cells provide a useful means to study the function of Kupffer cells in vitro.

Entities:  

Keywords:  Attachment; C57BL/6 mouse; DAPI, 4′,6-Diamidino-2-phenylindole; DMEM, Dulbecco's modified Eagle's medium; ELISA, enzyme-linked immunosorbent assay; FC, flow cytometry; GM-CSF, granulocyte-macrophage colony-stimulating factor; Immortalization; Kupffer cells; Mixed hepatocyte culture; RT-PCR, Reverse transcription polymerase chain reaction; Shaking

Year:  2014        PMID: 25379377      PMCID: PMC4213843          DOI: 10.1016/j.rinim.2014.08.001

Source DB:  PubMed          Journal:  Results Immunol        ISSN: 2211-2839


  42 in total

1.  Isolation, purification, and characterization of liver cell types.

Authors:  H F Hendriks; A Brouwer; D L Knook
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Macrophage fusion and multinucleated giant cells of inflammation.

Authors:  Amy K McNally; James M Anderson
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

3.  Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line.

Authors:  Takato Takenouchi; Kazumasa Ogihara; Mitsuru Sato; Hiroshi Kitani
Journal:  Biochim Biophys Acta       Date:  2005-08-15

Review 4.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

5.  Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains.

Authors:  Yoshifumi Iwamaru; Takato Takenouchi; Kazumasa Ogihara; Megumi Hoshino; Masuhiro Takata; Morikazu Imamura; Yuichi Tagawa; Hiroko Hayashi-Kato; Yuko Ushiki-Kaku; Yoshihisa Shimizu; Hiroyuki Okada; Morikazu Shinagawa; Hiroshi Kitani; Takashi Yokoyama
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

Review 6.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

Review 7.  Monocytes and macrophages as cellular targets in liver fibrosis.

Authors:  Felix Heymann; Christian Trautwein; Frank Tacke
Journal:  Inflamm Allergy Drug Targets       Date:  2009-09

8.  Establishment of immortalized rat Kupffer cell lines.

Authors:  Yanhua Peng; Michel M Murr
Journal:  Cytokine       Date:  2007-05-14       Impact factor: 3.861

Review 9.  Purinergic signaling in giant cell formation.

Authors:  Irma Lemaire; Simonetta Falzoni; Elena Adinolfi
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Characterization of the liver-macrophages isolated from a mixed primary culture of neonatal swine hepatocytes.

Authors:  Hiroshi Kitani; Miyako Yoshioka; Takato Takenouchi; Mitsuru Sato; Noriko Yamanaka
Journal:  Results Immunol       Date:  2014-01-23
View more
  13 in total

Review 1.  Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.

Authors:  Qi Liu; Xiang Wang; Tian Xia
Journal:  Anal Bioanal Chem       Date:  2018-08-01       Impact factor: 4.142

Review 2.  Liver 'organ on a chip'.

Authors:  Colin H Beckwitt; Amanda M Clark; Sarah Wheeler; D Lansing Taylor; Donna B Stolz; Linda Griffith; Alan Wells
Journal:  Exp Cell Res       Date:  2017-12-29       Impact factor: 3.905

3.  Efficient and simple approach to in vitro culture of primary epithelial cancer cells.

Authors:  Karolina Janik; Marta Popeda; Joanna Peciak; Kamila Rosiak; Maciej Smolarz; Cezary Treda; Piotr Rieske; Ewelina Stoczynska-Fidelus; Magdalena Ksiazkiewicz
Journal:  Biosci Rep       Date:  2016-12-09       Impact factor: 3.840

4.  Angiotensin II subtype 1a receptor signaling in resident hepatic macrophages induces liver metastasis formation.

Authors:  Yuki Shimizu; Hideki Amano; Yoshiya Ito; Tomohiro Betto; Sakiko Yamane; Tomoyoshi Inoue; Nobuyuki Nishizawa; Yoshio Matsui; Mariko Kamata; Masaki Nakamura; Hidero Kitasato; Wasaburo Koizumi; Masataka Majima
Journal:  Cancer Sci       Date:  2017-07-27       Impact factor: 6.716

5.  Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.

Authors:  Moris Sangineto; Felix Grabherr; Timon E Adolph; Christoph Grander; Simon Reider; Nikolai Jaschke; Lisa Mayr; Julian Schwärzler; Marcello Dallio; Alexander R Moschen; Antonio Moschetta; Carlo Sabbà; Herbert Tilg
Journal:  Liver Int       Date:  2020-05-06       Impact factor: 5.828

6.  The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice.

Authors:  Indu G Rajapaksha; Kai Y Mak; Ping Huang; Louise M Burrell; Peter W Angus; Chandana B Herath
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

7.  LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH.

Authors:  Noboru Takata; Kiyo-Aki Ishii; Hiroaki Takayama; Mayumi Nagashimada; Kyoko Kamoshita; Takeo Tanaka; Akihiro Kikuchi; Yumie Takeshita; Yukako Matsumoto; Tsuguhito Ota; Yasuhiko Yamamoto; Satoshi Yamagoe; Akihiro Seki; Yoshio Sakai; Shuichi Kaneko; Toshinari Takamura
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

8.  Infusion of Kupffer Cells Expanded in Vitro Ameliorated Liver Fibrosis in a Murine Model of Liver Injury.

Authors:  Weina Li; Fei He
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

9.  Distinguishing functional exosomes and other extracellular vesicles as a nucleic acid cargo by the anion-exchange method.

Authors:  Naohiro Seo; Junko Nakamura; Tsuguhiro Kaneda; Hiroaki Tateno; Asako Shimoda; Takanori Ichiki; Koichi Furukawa; Jun Hirabayashi; Kazunari Akiyoshi; Hiroshi Shiku
Journal:  J Extracell Vesicles       Date:  2022-03

10.  Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.

Authors:  Kook Hwan Kim; Seong Hun Kim; Dai Hoon Han; Young Suk Jo; Yong-Ho Lee; Myung-Shik Lee
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.